The second leading cause of maternal death is pre-eclampsia/eclampsia—most often detected through the elevation of blood pressure during pregnancy—which can lead to seizures, kidney and liver damage, and both maternal and infant deaths, if untreated. These conditions claim the lives of an estimated 63,000 women each year, as well as the lives of many of their babies.1 Where a woman gives birth should not decide her fate, and yet the risk that a woman in a developing country will die of pre-eclampsia/eclampsia is approximately 300 times higher than that for a woman in a developed country.1 Several studies have identified magnesium sulfate (MgSO4) as the most effective anticonvulsant for preventing and treating the life-threatening seizures of eclampsia. MgSO4 is needed at every level of the health care system where deliveries occur, from urban hospitals to rural clinics.2 Most of women with pre-eclampsia will also require antihypertensive therapy, even while on MgSO4.10 Supportive policies and appropriate practices are required to take this important medicine to scale to help reach the Millennium Development Goal (MDG) 5 target: reducing maternal mortality by 75% by 2015.
Launched by UN Secretary-General Ban Ki-moon during the United Nations Millennium Development Goals Summit in September 2010, Every Woman Every Child aims to save the lives of 16 million women and children by 2015. It is an unprecedented global movement that mobilizes and intensifies international and national action by governments, multilaterals, the private sector and civil society to address the major health challenges facing women and children around the world. The effort puts into action the Global Strategy for Women’s and Children’s Health, which presents a roadmap on how to enhance financing, strengthen policy and improve service on the ground for the most vulnerable women and children. - See more at: http://www.everywomaneverychild.org/about#sthash.8kbfTSh7.dpuf
Publicly available: yes
Countries where available: Worldwide
Price range (USD): contact supplier for quote
documentation, article, or review: https://path.azureedge.net/media/documents/TS_pee_mgso4.pdf
If you are aware of any updates to the Magnesium Sulfate to Fight Preeclampsia and Eclampsia project please complete the form or send an email to [email protected]